Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.
about
Prospects and progress of immunotherapy for bladder cancer.The evolving genomic landscape of urothelial carcinoma.Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment.Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.Exome-Wide Association Study of Pancreatic Cancer Risk.
P2860
Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Spectrum of genomic alteration ...... advanced urothelial carcinoma.
@en
type
label
Spectrum of genomic alteration ...... advanced urothelial carcinoma.
@en
prefLabel
Spectrum of genomic alteration ...... advanced urothelial carcinoma.
@en
P2860
P356
P1433
P1476
Spectrum of genomic alteration ...... advanced urothelial carcinoma.
@en
P2093
Nan Sethakorn
Peter H O'Donnell
P2860
P304
P356
10.1111/BJU.13552
P577
2016-06-07T00:00:00Z